Aug 14, 2020
Phase 2/3 trial suggests that AMZELL's new topical treatment (AMZ001) for the treatment of knee osteoarthritis symptoms is effective
Jun 17, 2020
ASC40 (TVB-2640) Significantly Reduced Liver Fat With a 61% Responder Rate in Phase 2 NASH Trial
Jun 01, 2020
Longeveron Announces Japanese Approval of Clinical Trial for Treatment of Aging Frailty With Longeveron's Stem Cells
May 14, 2020
Milestone Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Apr 03, 2020
Axon Presented Positive Phase II Trial Results of AADvac1 at AAT-AD/PD 2020
Mar 23, 2020
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
Feb 27, 2020
Clene Nanomedicine Presents Blinded Interim Data from the VISIONARY-MS Phase 2 Study
Feb 19, 2020
Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643
Feb 06, 2020
French Biotech TargEDys® Announces Positive Results of Its Clinical Trial With Its Probiotic Strain Hafnia alvei HA4597(TM) on the Weight Loss Thanks to Regulation of Appetite
Dec 12, 2019
COMPASS Pathways and King's College London Announce Results From Psilocybin Study In Healthy Volunteers
Dec 06, 2019
Grifols presents its latest Alzheimer's clinical trial data
Dec 05, 2019
EIP Pharma Announces Presentation of Phase 2b Clinical Trial Results of Neflamapimod in Early-stage Alzheimer's Disease at Clinical Trials in Alzheimer's Disease (CTAD) meeting
Nov 14, 2019
Two Recent Human Clinical Trials Establish Algae Health Science's AstaZine® as the Astaxanthin Category Leader for Brain Health
Nov 11, 2019
Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019
Oct 28, 2019
Microbion Corporation Announces Results from Randomized, Double Blind, Placebo-Controlled Phase 1b Trial of Pravibismane (MBN-101) for Treatment of Moderate to Severe Chronic Infected Diabetic Foot Ulcers
Oct 21, 2019
United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study
Oct 15, 2019
Relmada Therapeutics Announces Top-Line Results from REL-1017 Phase 2 Study in Individuals with Treatment Resistant Depression
Oct 11, 2019
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.
Oct 02, 2019
EMGALITY(TM) (galcanezumab) now available in Canada for preventive treatment of migraine
Sep 24, 2019
Clinical Data Published from RepliCel's Skin Rejuvenation Study